This content is only available via PDF.
©1997 American Association for Cancer Research.
1997
American Association for Cancer Research, Inc.
Advertisement
Andreas S. Lübbe; Correspondence re: A. S. Lübbe et al., Preclinical Experiences with Magnetic Drug Targeting: Tolerance and Efficacy. Cancer Res., 56: 4694–4701, 1996; and Clinical Experiences with Magnetic Drug Targeting: A Phase I Study with 4′-Epidoxorubicin in 14 Patients with Advanced Solid Tumors. Cancer Res., 56: 4686–4693, 1996—Reply. Cancer Res 15 July 1997; 57 (14): 3064–3065.
Download citation file:
Advertisement